TagPharmaceutical Benefits Scheme (PBS)

On World Hepatitis Day it’s time to talk about HIV and hepatitis C

O

National Association of people with HIV Australia, July 28 2016 On World Hepatitis Day, the National Association of People with HIV Australia (NAPWHA), the Australian Federation of AIDS Organisations (AFAO), the Kirby Institute and Hepatitis Australia are raising awareness about HIV and hepatitis C (HCV) co-infection. An estimated 3,000 Australians are living both with HIV and HCV. HCV is more...

TGA approval of PrEP for HIV in Australia

T

6 MAY 2016 — The Victorian AIDS Council (VAC) The Victorian AIDS Council (VAC) has welcomed the news today that the Therapeutic Goods Administration (TGA) has approved the drug Truvada for use as PrEP (pre-exposure prophylaxis for HIV) in Australia. TGA approval means doctors in Australia no longer have to prescribe Truvada as PrEP “off-label”, that is, for something other than its previously...

PrEP: HIV drug trials expanding to 2,000 men in Qld after ‘brave’ government decision

P

ABC News, 27/04/16, 5:12pm
A groundbreaking new drug tipped to stop the spread of HIV within just a few years will be available to more than 2,000 Queensland men under a $6 million trial program.
The trials make Pre-Exposure Prophylaxis (PrEP) available to men who have sex with men, as a means of preventing HIV transmission.
Read more here

New Treatments for Hepatitis C: the facts

N

Hepatitis NSW, 2016 This is a really exciting time if you live in Australia and have hep C. The Federal government has announced that new direct acting antiviral (DAA) treatment drugs will be free and available to you from 1 March 2016. The new treatments are: Harvoni® (sofosbuvir/ledipasvir) two drugs combined in each pill Sovaldi® and Daklinza® (sofosbuvir and daclatasvir) separate pills, taken...

Rising Death Toll from Viral Hepatitis in Australia

R

Hepatitis NSW, September 2015 On 14 September, the Kirby Institute released the HIV, viral hepatitis and sexually transmissible infections in Australia: Annual Surveillance Report 2015. And it made for particularly sobering reading. It is estimated that 690 people died from hepatitis C-related liver disease in 2014, which represents an increase of 146% from ten years earlier. The number of people...

Your sidebar area is currently empty. Hurry up and add some widgets.